Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Marathon Pharmaceuticals logo — From pioneering therapies for rare diseases to advanced pedi...

Marathon Pharmaceuticals

From pioneering therapies for rare diseases to advanced pediatric care, delivering hope and quality care when it matters most.

Founded 2008 Biotechnology, Health Care +1

General Information

Company Name Marathon Pharmaceuticals
Founded Year 2008
Industries Biotechnology, Health Care, Manufacturing
Social

Get notified when Marathon Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Marathon Pharmaceuticals

Marathon Pharmaceuticals is a biotechnology and healthcare company founded in 2008, with a focus on developing treatment options for rare diseases. The company is dedicated to creating small-volume, hard-to-manufacture medications often overlooked by larger pharmaceutical companies. Its recent establishment, the Marathon Bioscience Center in Chicago, demonstrates the company's commitment to advancing treatments for various diseases, including cancer, central nervous system diseases, movement disorders, gastrointestinal diseases, and endocrine deficiencies. The company's pursuit of delivering hope and quality care is evident through its development of therapies for rare diseases, rare cancers, and neurological conditions. Marathon Pharmaceuticals collaborates with clinical, research, and regulatory staff to produce next-generation treatments and has developed medications like Amytal Sodium, Seconal Sodium, Opium Tincture, and Pepcid for various healthcare needs. One of the widely recognized treatments from Marathon is ZiNGO, a single-use powdered lidocaine device used in pediatric patients before procedures requiring venous access. This innovative device reduces the time needed to administer local anesthesia for such procedures. The company's products have been positively impacting thousands of patients nationwide. Marathon's dedication to delivering therapies to patients in need, especially those requiring high-need, hard-to-manufacture medications, showcases its commitment to healthcare innovation and patient care.

Taxonomy: pharmaceuticals, rare diseases, pediatric care, drug development, bioscience, treatments, cancer therapies, neurological conditions, gastrointestinal disorders, clinical research, medical innovation, healthcare stakeholders, quality medications, innovative devices

No funding data available for Marathon Pharmaceuticals yet.

Get notified when Marathon Pharmaceuticals raises funding

FAQ About Marathon Pharmaceuticals

From pioneering therapies for rare diseases to advanced pediatric care, delivering hope and quality care when it matters most.
Marathon Pharmaceuticals was founded in 2008.
Marathon Pharmaceuticals operates in the following industries: Biotechnology, Health Care, Manufacturing.

We're actively collecting intelligence on Marathon Pharmaceuticals.

Track Marathon Pharmaceuticals to get notified

Don't just browse. Track.

Signal Tracker monitors Marathon Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy